Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy And Use As Monotherapy.
NCT04721821 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7807
Last updated 2024-04-12
Summary
This study is to investigate if there has been a shift in treatment with tofacitinib, assessing real world patient data and entered in the Corrona registry between 2016 and 2020.
Conditions
- Arthritis Rheumatoid
Interventions
- DRUG
-
Tofacitinib
Patients who received Tofacitinib for RA
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-22
- Primary Completion
- 2021-11-29
- Completion
- 2021-11-29
Countries
- United States
Study Locations
More Related Trials
-
Patient-Reported Outcomes In Rheumatoid Arthritis Patients Treated With Tofacitinib Or Biological Disease-Modifying Antirheumatic Drugs (DMARDs) In Real Life Conditions
NCT03073109 ·Status: COMPLETED
-
A Study of Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
NCT01089023 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Analysis of Adherence and Effectiveness Outcomes Between Rheumatoid Arthritis (RA) Patients Treated With Tofacitinib Modified Release (MR)
NCT04018001 ·Status: COMPLETED
-
TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE
NCT04413617 ·Status: COMPLETED ·Phase: PHASE2
-
A Study To Evaluate The Safety And Efficacy Of Tofacitinib Modified Release Tablets Compared To Tofacitinib Immediate Release Tablets In Adult Patients With Rheumatoid Arthritis
NCT02281552 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis
NCT06654882 ·Status: RECRUITING ·Phase: PHASE3
-
Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis
NCT05572567 ·Status: COMPLETED
-
Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis
NCT02831855 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of The Effect of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate on Articular Damage in The Hand in Patients With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response to Non-Biological DMARDs
NCT01878318 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid Arthritis
NCT01462162 ·Status: COMPLETED
-
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
NCT01976364 ·Status: COMPLETED ·Phase: PHASE3
-
ToFAcitinib in Early Active Axial SpondyloarThritis:
NCT06112665 ·Status: RECRUITING ·Phase: PHASE4
-
Predictors of Response to Tofacitinib Treatment in Rheumatoid Arthritis Patients
NCT04079920 ·Status: COMPLETED
-
A Retrospective, Observational Chart Review of Biologics in Monotherapy Versus the Combination Biologic Plus Methotrexate in Patients With Rheumatoid Arthritis
NCT01866150 ·Status: COMPLETED
-
Safety of TofAcitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA)-Cancer Endpoints
NCT04798287 ·Status: COMPLETED
-
A Study of Tocilizumab (RoActemra) in Tocilizumab-Naive Participants With Rheumatoid Arthritis and Inadequate Response to Non-Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) and/or Biologic Therapy
NCT02001987 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness and Safety of Tofacitinib in Korean Patients With Rheumatoid Arthritis
NCT03011281 ·Status: UNKNOWN
-
A Study of Tocilizumab and Methotrexate Treatment Strategies (Adding Tocilizumab to Methotrexate Versus Switching to Tocilizumab) in Patients With Active Rheumatoid Arthritis With Inadequate Response to Prior Methotrexate Treatment
NCT00810199 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA)
NCT01164579 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study of the Impact of RoActemra/Actemra on Fatigue in Patients With Rheumatoid Arthritis (PEPS)
NCT01185522 ·Status: COMPLETED
-
A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent
NCT02046603 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) Therapy
NCT03155347 ·Status: COMPLETED ·Phase: PHASE3
-
A Retrospective Observational Study on the Use of Biologics in Monotherapy in Patients With Rheumatoid Arthritis
NCT01834807 ·Status: COMPLETED
-
An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical Practice
NCT01474291 ·Status: COMPLETED
-
A Non-Interventional Study in Patients With Rheumatoid Arthritis Who Are Treated With RoActemra/Actemra (Tocilizumab)
NCT01893255 ·Status: WITHDRAWN